Globus Medical (GMED) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Globus Medical (GMED) PT Raised to $30 at BofA/Merrill Lynch Following Q4, Branch Deal
February 26, 2015 8:37 AM ESTBofA/Merrill Lynch analyst Bob Hopkins reiterated a Buy rating and boosted his price target on Globus Medical (NYSE: GMED) to $30.00 (from $26.00) following Q4 results and the acquisition of Branch.
Hopkins calls Branch a controversial but accretive deal. He also said guidance seems... More
